Silo Pharma, Inc. Annual Operating Income (Loss) in USD from 2017 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Silo Pharma, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2017 to 2023.
  • Silo Pharma, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$1M, a 10.1% increase year-over-year.
  • Silo Pharma, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$3.82M, a 15.6% increase year-over-year.
  • Silo Pharma, Inc. annual Operating Income (Loss) for 2023 was -$3.86M, a 6.28% decline from 2022.
  • Silo Pharma, Inc. annual Operating Income (Loss) for 2022 was -$3.63M, a 32.2% decline from 2021.
  • Silo Pharma, Inc. annual Operating Income (Loss) for 2021 was -$2.74M, a 24.6% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$3.86M -$228K -6.28% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-25
2022 -$3.63M -$883K -32.2% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-25
2021 -$2.74M -$543K -24.6% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-24
2020 -$2.2M -$1.27M -137% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-28
2019 -$930K -$336K -56.6% Jan 1, 2019 Dec 31, 2019 10-K/A 2021-05-17
2018 -$594K -$103K -21.1% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-20
2017 -$491K Jan 1, 2017 Dec 31, 2017 10-K 2019-04-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.